Evidence map›Paper›PMID 19469887›Full record

ArticleExperimental dermatology2009

The role of CD44 in cutaneous inflammation.

Mona Man, Peter M Elias, Wenyan Man, Yan Wu, Lilly Y W Bourguignon, Kenneth R Feingold, Mao-Qiang Man

Open access · greenAbstract read
In one paragraph

Article in Experimental dermatology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Therapeutic Effect of Darkling Beetle (Veterinary sciences · 2021
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Mona ManDepartment of Dermatology, University of California School of Medicine, San Francisco, CA, USA.
Peter M Elias
Wenyan Man
Yan Wu
Lilly Y W Bourguignon
Kenneth R Feingold
Mao-Qiang Man
University of California, San Francisco · US

Funding

RELATIONSHIP OF PERMEABILITY BARRIER FUNCTION AND EPIDERMAL CYTOKINE PRODUCTIONP01AR039448 · NIAMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI BIKLE, DANIEL DAVID · 1988 to 2007
$11.8M
NATURE OF THE MAMMALIAN CUTANEOUS PERMEABILITY BARRIERR01AR019098 · NIAMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI ELIAS, PETER M · 1986 to 2012
$4.2M
CD44/VARIANT CYTOSKELETON IN BREAST CANCER PROGRESSIONR01CA066163 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BOURGUIGNON, LILLY YW · 1995 to 2010
$2.6M
CD44-P185HER2 INTERACTION IN OVARIAN CANCER PROGRESSIONR01CA078633 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BOURGUIGNON, LILLY YW · 1999 to 2007
$2.5M
PPARs and LXR Regulate Epidermal DifferentiationR01AR050629 · NIAMS · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI FEINGOLD, KENNETH R · 2004 to 2006
$432k
NCI NIH HHS R01 CA066163NCI NIH HHS R01 CA078633NIAMS NIH HHS AR 050629NIAMS NIH HHS AR 19098NIAMS NIH HHS P01 AR039448NIAMS NIH HHS R01 AR019098NIAMS NIH HHS R01 AR050629
6 · The paper itself

Abstract

CD44 is a transmembrane glycoprotein expressed in various tissues including the skin. Previous studies indicated that CD44 is required for epidermal permeability barrier homeostasis and keratinocyte differentiation. Yet, while some studies have demonstrated that CD44 is critical for the development of inflammation, others have shown that CD44 is not essential for the development of cutaneous inflammation. In this study, we evaluated the changes in epidermal CD44 expression in a variety of skin inflammatory models and determined whether CD44 is required for the development of cutaneous inflammation. Inflammatory responses were compared in CD44 KO versus wild-type mice in acute models of irritant and allergic contact dermatitis, as well as in a subacute allergic contact dermatitis induced by repeated hapten treatment. Inflammatory responses were assessed by measuring ear thickness and epidermal hyperplasia in haematoxylin & eosin-stained sections. Our results demonstrate that: (i) epidermal CD44 expression increases in both acute and subacute cutaneous inflammatory models; and (ii) acute disruption of the epidermal permeability barrier function increases epidermal CD44 expression. Whereas inflammatory responses did not differ between CD44 KO and wild-type mice in acute models of irritant and allergic contact dermatitis, both inflammatory responses and epidermal hyperplasia increased in CD44 KO mice following repeated hapten challenges. These results show first, that permeability barrier disruption and inflammation stimulate epidermal CD44 expression, and second, that CD44 modulates epidermal proliferation and inflammatory responses in a subacute murine allergic contact dermatitis model.

Indexed as

Gene Expression RegulationAnimalsCytokinesDermatitis, ContactDisease Models, AnimalEpidermisFemaleGlycoproteinsHyaluronan ReceptorsHyperplasiaInflammationKeratinocytesMiceMice, KnockoutSkinCd44 protein, mouseCytokinesGlycoproteinsHyaluronan Receptors

Identifiers

PMID19469887
PMCPMC2784008
OpenAlexW1969344014

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.